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INTRODUCTION:  The  clinical  behavior  of  desmoid  tumors  can  be unpredictable,  particularly  when  they
arise  in  the ante-partum  or post-partum  period.  We  present  a case  of an  intra-abdominal  desmoid  tumor
that was  identiﬁed  in the  ante-partum  period,  progressed  rapidly  in  the post-partum  period,  and  was
subsequently  resected.
PRESENTATION OF  CASE:  The  patient  is a 19 year-old  female  who  was  found  to  have  a  12 cm  intra-
abdominal  mass  on  a fetal  assessment  ultrasound.  The  decision  was  made  to  observe  the  patient  and
monitor  the  mass  for growth.  However,  the mass  rapidly  grew  in the  post-partum  period.  The  patient
was  transferred  to our  institution  after  an exploratory  laparotomy  revealed  a large  intra-abdominal  mass
emanating  from  the  small  bowel  mesentery.  The  30 cm ×  24 cm × 16 cm mass  was  successfully  resected
with  negative  margins,  and the  pathologic  diagnosis  of  desmoid  tumor  was  conﬁrmed.  The  patient  had
an  uncomplicated  post-operative  course  and  was discharged  on  post-operative  day  6.
DISCUSSION:  The  majority  of  pregnancy-associated  desmoid  tumors  are  in  the abdominal  wall,  arising
from  the rectus  abdominus  muscle  or  from  previous  Cesarean  section  scars.  These  tumors  may  sponta-
neously  regress  in  the post-partum  period  and  therefore,  patients  with  these  tumors  are often  observed.
Close  follow-up  is  important  so  that rapid  tumor  progression,  which  may  lead  to unresectability,  can  be
identiﬁed  and managed  appropriately.
CONCLUSION:  A  patient  with  a rare  case of a giant  pregnancy-associated,  intra-abdominal  desmoid  tumor
that rapidly  progressed  in  the  post-partum  period  and  was  successfully  treated  with  surgical  resection
with  negative  margins.
©  2016  The  Authors.  Published  by Elsevier  Ltd  on  behalf  of IJS  Publishing  Group  Ltd.  This  is an  open
he CCaccess  article  under  t
. Introduction
Desmoid tumors are rare benign tumors exhibiting ﬁbroblastic
roliferation that typically arise from fascial or musculo-
poneurotic structures [1]. They account for 0.03% of all
ocumented neoplasms and approximately 3% of all soft tissue
umors, with an incidence of 2–4 per million per year [2]. These
umors have a propensity to inﬁltrate surrounding structures,
ather than metastasize, and have the potential to cause signiﬁcant
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morbidity and mortality due to pressure effects and obstruction
of vital organs. According to consensus-based guidelines from the
National Comprehensive Cancer Network (NCCN), surgical resec-
tion should be attempted if technically feasible in symptomatic
patients or in patients with tumors that pose imminent risk to
surrounding structures [3]. However, the clinical progression and
behavior of these tumors can be unpredictable, particularly when
they occur in the ante-partum or post-partum period in women.
We present a case of a giant intra-abdominal desmoid tumor
that rapidly progressed in the post-partum period and was suc-
cessfully resected.
2. Presentation of caseThe patient is a 19 year old female who was found to have an
intra-abdominal mass that measured 12 cm in greatest dimension
during a fetal assessment ultrasound which was performed at 34
roup Ltd. This is an open access article under the CC BY-NC-ND license (http://
 –  OPEN  ACCESS
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eeks gestation. The patient was asymptomatic and the decision
as made to proceed with observation. The patient had a successful
pontaneous vaginal delivery without complications in December
015. In the ﬁrst post-partum week, the patient continued to report
hortness of breath and abdominal pressure. A computed tomogra-
hy (CT) scan was performed on December 31, 2015 which showed
hat the mass measured 14 cm × 13 cm × 13 cm and appeared to be
ttached to the uterus, suggestive of an exophytic ﬁbroid. Again the
ecision was made to continue with observation.
Over the next 3 months, the patient’s abdominal girth con-
inued to increase. A follow-up MRI  on April 1, 2016 showed
hat the mass had increased signiﬁcantly in size, measuring
3 cm × 22 cm × 13 cm,  and was potentially consistent with a
esmoid tumor. The patient’s only symptoms were increasing
hortness of breath and abdominal pressure; she did not experience
ny change in bowel habits. The patient had no prior medical his-
ory or surgical history, and no family history of a similar condition,
olorectal cancer, or familial adenomatous polyposis (FAP).
The patient was transferred to our institution with a negative
ressure abdominal wound dressing on the evening of May  13, 2016
mmediately after exploratory laparotomy at an outside hospital
evealed a normal uterus and ovaries and a large intra-abdominal
ass that was emanating from the small bowel mesentery. A CT
ngiogram of the abdomen and pelvis was performed to evalu-
te the vascular distribution to the mass and the small bowel. This
howed a large mass ﬁlling the entire abdomen and displacing the
owel with a vascular supply from the superior mesenteric artery
SMA) (Fig. 1A–C). The proximal branches of the SMA  supplying the
mall bowel and colon appeared to be separate from the mass.
The patient was taken to the operating room for surgical explo-
ation. This demonstrated that the mass originated from the distal
mall bowel mesentery and a loop of small bowel was adherent
o and inseparable from the mass (Fig. 2A). The small bowel was
xamined and it appeared that the patient would have sufﬁcient
mall bowel remaining after resection. The mass was successfully
esected en bloc with part of the ileum. A small portion of the ter-
inal ileum, the ileocecal valve, and the middle colic artery and
ascular supply to the proximal small bowel were preserved. The
ass measured 30 cm × 24 cm × 16 cm (Fig. 2B). Pathology con-
rmed the diagnosis of desmoid tumor with negative surgical
argins. (Fig. 3) The tumor was negative for estrogen and proges-
erone receptor. The patient had an uncomplicated post-operative
ourse and was discharged on post-operative day 6.
On multidisciplinary review of the patient’s case, adjuvant radi-
tion therapy was not recommended due to the documented
egative margins and tumor location [3]. The patient had no com-
laints at a 3-month follow-up clinic visit, and upper and lower
ndoscopic studies done at that time showed no evidence of polyps.
er NCCN guidelines, the patient will be followed with history,
hysical exam and imaging every 6 months for 2 years [3].
. Discussion
Desmoid tumors are rare tumors that can occur anywhere in
he body and have quite variable clinical behavior. The majority
f desmoid tumors arise sporadically, while 5–15% are associ-
ted with familial adenomatous polyposis (FAP) [4,5]. Up to 20%
f patients with FAP will develop a desmoid tumor, most which
ccur intra-abdominally or in the abdominal wall and arise at the
ite of prior surgical anastomoses or incisions. Sporadic desmoid
umors are more commonly located in the abdominal wall or at
xtra-abdominal locations, have a lower mortality rate than those
ssociated with FAP, and have a higher rate of spontaneous regres-
ion [4,6]. Small retrospective studies have shown spontaneous
egression rates of up to 29% in patients with sporadic desmoid
Fig. 1. (A–C): CT angiogram of abdomen and pelvis demonstrating a large intra-
abdominal mass with vascular supply from the superior mesenteric artery.
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Fig. 2. (A) Intra-operative view of intra-abdominal desmoid tumor with adhe
F
i
t
i
a
p
p
sig. 3. The tumor consists of bland spindle cells with abundant ﬁbrotic stroma. There
s  minimal mitotic activity (Hematoxylin & Eosin Stain, bar = 300 m).
umors and 5-year progression-free survival rates of 50% in patients
nitially managed with observation [7,8].
Although the molecular events surrounding tumor formation
re not completely understood, dysregulation of the Wnt  signaling
athway, leading to accumulation of beta-catenin and ﬁbroblast
roliferation, appears to play a role in the development of both
poradic and FAP-associated desmoid tumors [9]. Hormonal factorsrent portion of small bowel. (B) Desmoid tumor after surgical resection.
may  also play a role in the development of pregnancy-associated
desmoid tumors. This hypothesis is supported by reports that
patients may  respond to anti-estrogen therapy and that sponta-
neous regression of pregnancy-associated desmoid tumors may
occur post-partum [10]. The vast majority of these tumors are in the
abdominal wall, arising from the rectus abdominus muscle or from
previous Cesarean section scars, while intra-abdominal tumors are
rare [11]. Therefore, patients who  develop pregnancy-associated
desmoid tumors may  often be observed rather than having surgi-
cal intervention. This approach was  initially utilized in our patient,
however, due to rapid growth of her tumor, surgical resection was
eventually required.
The management of patients with desmoid tumors is controver-
sial for several reasons. While some desmoid tumors can be locally
aggressive and inﬁltrate surrounding tissues, others have a very
indolent course. Although the majority of patients with desmoid
tumors become symptomatic, the mortality rate is low [12]. Addi-
tionally, desmoid tumors are rare and this makes it difﬁcult for
investigators to study different treatment approaches.
In the past, surgical resection was considered the mainstay of
treatment for both extra-abdominal and intra-abdominal desmoid
tumors. However, more groups are now adopting a “wait and see”
approach given the signiﬁcant variability in clinical behavior [9,13].
In cases where resection is necessary, the surgical approach should
balance complete tumor removal while minimizing functional and
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esthetic morbidity. There is controversy regarding the impact of
icroscopically positive margins on local recurrence [12,14,15].
hus, microscopically positive margins are acceptable in cases
here achieving negative margins would dramatically increase
perative morbidity.
Multimodal therapy for desmoid tumors may  involve adju-
ant radiotherapy as well as neoadjuvant and adjuvant systemic
herapies. Radiation therapy is an effective therapeutic option for
atients with unresectable tumors or for patients who are not good
urgical candidates. It may  also improve local control rates and
ay  be particularly helpful in patients with microscopically posi-
ive surgical margins [16]. Systemic therapy is typically utilized in
atients with multiple local recurrences or where surgical resec-
ion would lead to signiﬁcant morbidity and mortality [1]. It may
lso be used preoperatively to improve surgical outcomes. Several
mall studies have also shown that anti-estrogen and non-steroidal
nti-inﬂammatory agents may  be effective in halting disease pro-
ression [17,18].
. Conclusion
Desmoid tumors are rare neoplastic tumors of ﬁbroblastic pro-
iferation that pose several management challenges due to the low
ncidence, variable disease progression, and lack of randomized
linical trials investigating treatment approaches. We  present a
are case of a giant pregnancy-associated intra-abdominal desmoid
umor that demonstrated rapid progression in the post-partum
eriod. The patient was successfully treated with surgical resec-
ion with negative margins. Spontaneous regression of desmoid
umors is possible in the post-partum period and observation has
een adopted at many institutions. Nonetheless, it is critical to
losely monitor these patients with clinical exam and imaging in
his period so that appropriate interventions can be instituted when
igns and symptoms of tumor progression develop.
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